Showing results (381-390 of 2,804) with videos related to
Sort By:
Pageof 281
Journal of Crohn'S & Colitis|April 16, 2021
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA RegistryMaría Chaparro, Ana Garre, Marisa Iborra, et al.Journal of Crohn'S & Colitis|April 15, 2021
Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn's Disease, a Randomised Controlled TrialTimna Naftali, Lihi Bar-Lev Schleider, Shlomo Almog, et al.Journal of Crohn'S & Colitis|November 1, 2022
Increased Risk of Cancer and Mortality in a Large French Population-Based Paediatric-Onset Inflammatory Bowel Disease Retrospective CohortClaire Dupont-Lucas, Ariane Leroyer, Delphine Ley, et al.Journal of Crohn'S & Colitis|October 3, 2022
Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease: A European Crohn's and Colitis Organisation [ECCO] Position PaperJurij Hanzel, Peter Bossuyt, Valerie Pittet, et al.Journal of Crohn'S & Colitis|September 15, 2022
Successful Dietary Therapy in Paediatric Crohn's Disease is Associated with Shifts in Bacterial Dysbiosis and Inflammatory Metabotype Towards Healthy ControlsCharlotte M Verburgt, Katherine A Dunn, Mohammed Ghiboub, et al.Journal of Crohn'S & Colitis|September 16, 2022
An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative ColitisSally Mortlock, Anton Lord, Grant Montgomery, et al.Journal of Crohn'S & Colitis|October 14, 2022
circSMAD4 Promotes Experimental Colitis and Impairs Intestinal Barrier Functions by Targeting Janus Kinase 2 Through Sponging miR-135a-5pJie Zhao, Zhiliang Lin, Pu Ying, et al.Journal of Crohn'S & Colitis|September 27, 2022
What are the Unmet Needs and Most Relevant Treatment Outcomes According to Patients with Inflammatory Bowel Disease? A Qualitative Patient Preference StudyElise Schoefs, Séverine Vermeire, Marc Ferrante, et al.Journal of Crohn'S & Colitis|November 27, 2023
Improved Clinical Outcomes With Early Anti-Tumour Necrosis Factor Alpha Therapy in Children With Newly Diagnosed Crohn's Disease: Real-world Data from the International Prospective PIBD-SETQuality Inception Cohort StudyRenz C W Klomberg, Hella C van der Wal, Martine A Aardoom, et al.Journal of Crohn'S & Colitis|January 21, 2024
Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS TrialAndres J Yarur, Michael V Chiorean, Julián Panés, et al.Pageof 281